The IPO for Recro Pharma, Inc. (NASDAQ: REPH) opened for trading at $8.53 after pricing 3,750,000 shares at $8 per ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE